ReposiTrak (NYSE:TRAK - Get Free Report)'s stock had its "hold (c+)" rating restated by equities research analysts at Weiss Ratings in a research report issued on Wednesday,Weiss Ratings reports.
Separately, Wall Street Zen lowered ReposiTrak from a "buy" rating to a "hold" rating in a research report on Friday, October 3rd. One equities research analyst has rated the stock with a Hold rating, According to MarketBeat, the stock has a consensus rating of "Hold".
Get Our Latest Stock Analysis on TRAK
ReposiTrak Trading Down 2.4%
Shares of NYSE TRAK traded down $0.36 during mid-day trading on Wednesday, reaching $14.83. 53,166 shares of the company's stock were exchanged, compared to its average volume of 53,048. The stock has a market capitalization of $271.09 million, a price-to-earnings ratio of 42.37 and a beta of 0.44. The company has a debt-to-equity ratio of 0.01, a current ratio of 6.09 and a quick ratio of 6.09. The firm's fifty day moving average is $16.47. ReposiTrak has a twelve month low of $13.86 and a twelve month high of $25.01.
ReposiTrak (NYSE:TRAK - Get Free Report) last released its quarterly earnings results on Monday, September 29th. The company reported $0.09 EPS for the quarter. The company had revenue of $5.76 million for the quarter. ReposiTrak had a return on equity of 14.25% and a net margin of 30.55%.
Insiders Place Their Bets
In other ReposiTrak news, CEO Randall K. Fields sold 7,500 shares of the firm's stock in a transaction that occurred on Tuesday, September 2nd. The stock was sold at an average price of $16.06, for a total value of $120,450.00. Following the completion of the transaction, the chief executive officer directly owned 87,000 shares in the company, valued at $1,397,220. This trade represents a 7.94% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Insiders sold 88,500 shares of company stock valued at $1,484,914 in the last ninety days. 44.00% of the stock is owned by company insiders.
Institutional Inflows and Outflows
A number of hedge funds have recently bought and sold shares of the stock. Ashford Capital Management Inc. grew its stake in ReposiTrak by 93.7% in the second quarter. Ashford Capital Management Inc. now owns 792,154 shares of the company's stock valued at $15,566,000 after purchasing an additional 383,283 shares in the last quarter. Tower Research Capital LLC TRC boosted its stake in shares of ReposiTrak by 397.3% during the 2nd quarter. Tower Research Capital LLC TRC now owns 3,620 shares of the company's stock worth $71,000 after acquiring an additional 2,892 shares during the period. BNP Paribas Financial Markets boosted its stake in shares of ReposiTrak by 63.5% during the 2nd quarter. BNP Paribas Financial Markets now owns 1,633 shares of the company's stock worth $32,000 after acquiring an additional 634 shares during the period. Jane Street Group LLC bought a new position in shares of ReposiTrak during the 2nd quarter worth approximately $802,000. Finally, Coldstream Capital Management Inc. boosted its stake in shares of ReposiTrak by 47,619.0% during the 2nd quarter. Coldstream Capital Management Inc. now owns 20,042 shares of the company's stock worth $394,000 after acquiring an additional 20,000 shares during the period. 27.35% of the stock is currently owned by institutional investors.
ReposiTrak Company Profile
(
Get Free Report)
Park City Group, Inc, a software-as-a-service provider, designs, develops, and markets proprietary software products in North America. The company offers ReposiTrak MarketPlace, a supplier discovery and B2B e-commerce solution; ReposiTrak Compliance and Food Safety solutions, which reduces potential regulatory and legal risk from their supply chain partners; and ReposiTrak Supply Chain solutions that enables customers to manage relationships with suppliers.
Read More
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider ReposiTrak, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and ReposiTrak wasn't on the list.
While ReposiTrak currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.